116 related articles for article (PubMed ID: 16761096)
1. Crystal structure of the MAP3K TAO2 kinase domain bound by an inhibitor staurosporine.
Zhou TJ; Sun LG; Gao Y; Goldsmith EJ
Acta Biochim Biophys Sin (Shanghai); 2006 Jun; 38(6):385-92. PubMed ID: 16761096
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the TAO2 kinase domain: activation and specificity of a Ste20p MAP3K.
Zhou T; Raman M; Gao Y; Earnest S; Chen Z; Machius M; Cobb MH; Goldsmith EJ
Structure; 2004 Oct; 12(10):1891-900. PubMed ID: 15458637
[TBL] [Abstract][Full Text] [Related]
3. Precisely ordered phosphorylation reactions in the p38 mitogen-activated protein (MAP) kinase cascade.
Humphreys JM; Piala AT; Akella R; He H; Goldsmith EJ
J Biol Chem; 2013 Aug; 288(32):23322-30. PubMed ID: 23744074
[TBL] [Abstract][Full Text] [Related]
4. Isolation of the protein kinase TAO2 and identification of its mitogen-activated protein kinase/extracellular signal-regulated kinase kinase binding domain.
Chen Z; Hutchison M; Cobb MH
J Biol Chem; 1999 Oct; 274(40):28803-7. PubMed ID: 10497253
[TBL] [Abstract][Full Text] [Related]
5. Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential.
Prade L; Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
Structure; 1997 Dec; 5(12):1627-37. PubMed ID: 9438863
[TBL] [Abstract][Full Text] [Related]
6. Involvement of p38 MAPK and ERK/MAPK pathways in staurosporine-induced production of macrophage inflammatory protein-2 in rat peritoneal neutrophils.
Xiao YQ; Someya K; Morita H; Takahashi K; Ohuchi K
Biochim Biophys Acta; 1999 Jun; 1450(2):155-63. PubMed ID: 10354507
[TBL] [Abstract][Full Text] [Related]
7. Structural studies of MAP Kinase cascade components.
Goldsmith EJ; Min X; He H; Zhou T
Methods Mol Biol; 2010; 661():223-37. PubMed ID: 20811986
[TBL] [Abstract][Full Text] [Related]
8. The three-dimensional structure of the ZAP-70 kinase domain in complex with staurosporine: implications for the design of selective inhibitors.
Jin L; Pluskey S; Petrella EC; Cantin SM; Gorga JC; Rynkiewicz MJ; Pandey P; Strickler JE; Babine RE; Weaver DT; Seidl KJ
J Biol Chem; 2004 Oct; 279(41):42818-25. PubMed ID: 15292186
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2.
Lawrie AM; Noble ME; Tunnah P; Brown NR; Johnson LN; Endicott JA
Nat Struct Biol; 1997 Oct; 4(10):796-801. PubMed ID: 9334743
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of inhibitor selectivity in MAP kinases.
Wang Z; Canagarajah BJ; Boehm JC; Kassisà S; Cobb MH; Young PR; Abdel-Meguid S; Adams JL; Goldsmith EJ
Structure; 1998 Sep; 6(9):1117-28. PubMed ID: 9753691
[TBL] [Abstract][Full Text] [Related]
11. MAP3Ks as central regulators of cell fate during development.
Craig EA; Stevens MV; Vaillancourt RR; Camenisch TD
Dev Dyn; 2008 Nov; 237(11):3102-14. PubMed ID: 18855897
[TBL] [Abstract][Full Text] [Related]
12. The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation.
Senger K; Pham VC; Varfolomeev E; Hackney JA; Corzo CA; Collier J; Lau VWC; Huang Z; Hamidzhadeh K; Caplazi P; Peng I; Setiadi AF; Francis R; Paler-Martinez A; Kwon YC; Ramirez-Carrozzi V; Sun Y; Grigg PW; Roose-Girma M; Jeet S; Barck KH; Pham A; Ota N; Ha C; Stinson J; Guillory J; Tam L; Modrusan Z; Emson C; McKenzie BS; Townsend MJ; Carano RAD; Warming S; Vucic D; DeVoss J; Lee WP; Lill JR; Zarrin AA
Sci Signal; 2017 Apr; 10(475):. PubMed ID: 28420753
[TBL] [Abstract][Full Text] [Related]
13. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
[TBL] [Abstract][Full Text] [Related]
14. MEK1/2 inhibitors in the treatment of gynecologic malignancies.
Miller CR; Oliver KE; Farley JH
Gynecol Oncol; 2014 Apr; 133(1):128-37. PubMed ID: 24434059
[TBL] [Abstract][Full Text] [Related]
15. Participation of various kinases in staurosporine induced apoptosis of RAW 264.7 cells.
Yamaki K; Hong J; Hiraizumi K; Ahn JW; Zee O; Ohuchi K
J Pharm Pharmacol; 2002 Nov; 54(11):1535-44. PubMed ID: 12495557
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction cascade in staurosporine-induced prostaglandin E(2) production by rat peritoneal macrophages.
Yamaki K; Yonezawa T; Ohuchi K
J Pharmacol Exp Ther; 2000 Apr; 293(1):206-13. PubMed ID: 10734171
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition.
Komander D; Kular GS; Bain J; Elliott M; Alessi DR; Van Aalten DM
Biochem J; 2003 Oct; 375(Pt 2):255-62. PubMed ID: 12892559
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?
Son Y; Cheong YK; Kim NH; Chung HT; Kang DG; Pae HO
J Signal Transduct; 2011; 2011():792639. PubMed ID: 21637379
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
20. Role of the amino-terminal domains of MEKKs in the activation of NF kappa B and MAPK pathways and in the regulation of cell proliferation and apoptosis.
Bonvin C; Guillon A; van Bemmelen MX; Gerwins P; Johnson GL; Widmann C
Cell Signal; 2002 Feb; 14(2):123-31. PubMed ID: 11781136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
